Pediatric pain screening identifies youth at risk of chronic pain in sickle cell disease.


Journal

Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624

Informations de publication

Date de publication:
03 2019
Historique:
received: 05 07 2018
revised: 28 09 2018
accepted: 13 10 2018
pubmed: 6 11 2018
medline: 13 11 2019
entrez: 6 11 2018
Statut: ppublish

Résumé

This study aimed to evaluate the preliminary validation and application of a pain screening tool to identify biopsychosocial risk factors for chronic pain in pediatric sickle cell disease (SCD) and classify youth with SCD into prognostic risk groups. Youth presenting to a pediatric SCD clinic completed the Pediatric Pain Screening Tool (PPST), a brief 9-item self-report questionnaire developed for rapid identification of risk in youth with pain complaints. Youth also completed a battery of standardized patient-reported outcomes, including pain characteristics, pain burden, functional disability, pain interference, depressive symptoms, pain catastrophizing, and fear of pain. Healthcare utilization was extracted from medical chart review. Seventy-three 8- to 18-year-olds (94% Black, 57% female) with SCD participated. The PPST demonstrated discriminant validity that ranged from fair to excellent (area under the curves (AUC) = 0.74-0.93, P values < 0.001) for identifying significant pain frequency, disability, pain interference, and psychosocial distress. Receiver operating characteristic curve analyses indicated that previously established cutoff scores were appropriate for the SCD sample. Participants were classified into low-risk (28.8%), medium-risk (38.4%), and high-risk (32.9%) groups, with significant group differences across measures, F(18, 116) = 6.67, P < 0.001. The high-risk group reported significantly higher pain intensity, pain frequency, pain burden, functional disability, pain interference, and depressive symptoms relative to both low-risk and medium-risk groups (P values < 0.005). The high-risk group demonstrated a pain and psychosocial profile consistent with chronic SCD pain. The PPST may be useful for efficiently identifying youth with chronic SCD pain or those at risk of poor outcomes.

Sections du résumé

BACKGROUND
This study aimed to evaluate the preliminary validation and application of a pain screening tool to identify biopsychosocial risk factors for chronic pain in pediatric sickle cell disease (SCD) and classify youth with SCD into prognostic risk groups.
METHOD
Youth presenting to a pediatric SCD clinic completed the Pediatric Pain Screening Tool (PPST), a brief 9-item self-report questionnaire developed for rapid identification of risk in youth with pain complaints. Youth also completed a battery of standardized patient-reported outcomes, including pain characteristics, pain burden, functional disability, pain interference, depressive symptoms, pain catastrophizing, and fear of pain. Healthcare utilization was extracted from medical chart review.
RESULTS
Seventy-three 8- to 18-year-olds (94% Black, 57% female) with SCD participated. The PPST demonstrated discriminant validity that ranged from fair to excellent (area under the curves (AUC) = 0.74-0.93, P values < 0.001) for identifying significant pain frequency, disability, pain interference, and psychosocial distress. Receiver operating characteristic curve analyses indicated that previously established cutoff scores were appropriate for the SCD sample. Participants were classified into low-risk (28.8%), medium-risk (38.4%), and high-risk (32.9%) groups, with significant group differences across measures, F(18, 116) = 6.67, P < 0.001. The high-risk group reported significantly higher pain intensity, pain frequency, pain burden, functional disability, pain interference, and depressive symptoms relative to both low-risk and medium-risk groups (P values < 0.005).
CONCLUSIONS
The high-risk group demonstrated a pain and psychosocial profile consistent with chronic SCD pain. The PPST may be useful for efficiently identifying youth with chronic SCD pain or those at risk of poor outcomes.

Identifiants

pubmed: 30393948
doi: 10.1002/pbc.27538
pmc: PMC6344304
mid: NIHMS993979
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e27538

Subventions

Organisme : NCATS NIH HHS
ID : UL1TR000454
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000454
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States
Organisme : NHLBI NIH HHS
ID : 1K23Hl133457-01A1
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL133457
Pays : United States

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Références

J Pediatr Psychol. 2014 Mar;39(2):204-21
pubmed: 23965298
Pain. 2003 Aug;104(3):639-46
pubmed: 12927636
Pain. 2015 Aug;156(8):1511-8
pubmed: 25906349
J Pain. 2016 Sep;17(9):963-71
pubmed: 27263990
J Pain. 2011 Jun;12(6):677-86
pubmed: 21354866
Pain. 2011 Jul;152(7):1600-7
pubmed: 21458162
J Pediatr Psychol. 2018 Apr 1;43(3):243-251
pubmed: 29048551
Pain. 2007 Sep;131(1-2):132-41
pubmed: 17267129
Eur J Haematol. 2014 Aug;93(2):89-95
pubmed: 24735098
Spine (Phila Pa 1976). 2002 Nov 15;27(22):2564-73
pubmed: 12435995
Pediatr Blood Cancer. 2016 Jun;63(6):1038-45
pubmed: 26853841
J Hosp Med. 2011 May;6(5):248-55
pubmed: 21661098
Pain. 2004 Apr;108(3):221-9
pubmed: 15030941
Explore (NY). 2018 May - Jun;14(3):177-211
pubmed: 29735382
J Pain. 2013 Jul;14(7):689-98
pubmed: 23642409
Clin J Pain. 2016 Jun;32(6):527-33
pubmed: 26379074
Pain. 1995 Apr;61(1):139-44
pubmed: 7644237
J Dev Behav Pediatr. 2000 Feb;21(1):58-69
pubmed: 10706352
J Natl Med Assoc. 2006 Jul;98(7):1109-13
pubmed: 16895280
Clin J Pain. 2001 Dec;17(4):341-9
pubmed: 11783815
Pain. 2006 Mar;121(1-2):77-84
pubmed: 16480823
Pain. 2014 Nov;155(11):2360-7
pubmed: 25180013
J Pain. 2002 Dec;3(6):461-70
pubmed: 14622732
J Pain. 2017 May;18(5):490-498
pubmed: 28065813
Pain. 2006 Aug;123(3):254-63
pubmed: 16644128
J Pain. 2016 Sep;17(9 Suppl):T70-92
pubmed: 27586832
Arthritis Rheum. 2003 Oct;48(10):2923-30
pubmed: 14558099
Qual Life Res. 2017 Mar;26(3):565-586
pubmed: 27913986
J Pain. 2013 Sep;14(9):975-82
pubmed: 23701707
J Pediatr Psychol. 1991 Feb;16(1):39-58
pubmed: 1826329
Ann Emerg Med. 2009 May;53(5):587-93
pubmed: 18926599

Auteurs

Soumitri Sil (S)

Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, Georgia.
Children's Healthcare of Atlanta, Atlanta, Georgia.

Lindsey L Cohen (LL)

Children's Healthcare of Atlanta, Atlanta, Georgia.
Department of Psychology, Georgia State University, Atlanta, Georgia.

Carlton Dampier (C)

Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, Georgia.
Children's Healthcare of Atlanta, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH